Neurodevelopmental Medicine, Kennedy Krieger Institute, Johns Hopkins University, Baltimore, Maryland, USA.
School of Medicine, Meharry Medical College, Nashville, Tennessee, USA.
Br J Haematol. 2023 Feb;200(3):377-380. doi: 10.1111/bjh.18575. Epub 2022 Dec 1.
Despite recent developmental screening guidelines, rates of neurodevelopmental disorders (NDDs) remain lower than expected in children with sickle cell disease (SCD). A retrospective chart review identified 276 eligible patients; 214 charts were available for developmental screening and 207 charts for autism-specific screening. Developmental surveillance/screening was conducted in 70% of charts and autism-specific screening in 19% of charts. Validated tools were used in 32% of developmental screenings and 92% of autism-specific screenings. Many children (57%) were screened outside recommended ages. In conclusion, children with SCD are not regularly receiving appropriate developmental screening and surveillance by their healthcare providers.
尽管有最近的发育筛查指南,但患有镰状细胞病 (SCD) 的儿童的神经发育障碍 (NDD) 发生率仍低于预期。一项回顾性图表审查确定了 276 名符合条件的患者;214 份图表可用于发育筛查,207 份图表用于自闭症特异性筛查。70%的图表进行了发育监测/筛查,19%的图表进行了自闭症特异性筛查。32%的发育筛查和 92%的自闭症特异性筛查使用了经过验证的工具。许多儿童(57%)的筛查年龄不在推荐范围内。总之,SCD 患儿的医疗服务提供者并未定期对其进行适当的发育筛查和监测。